Charles River Will Buy WuXi PharmTech

April 27, 2010
Charles River Laboratories has agreed to buy WuXi PharmTech, in a deal that Bloomberg News calls the "largest foreign takeover of a Chinese company" to date. The move eliminates a potential competitor for Charles River and gives it an instant major presence in the Chinese contract research and manufacturing market. For the full story, click here.